 |
Code of Federal Regulations (Last Updated: October 10, 2024) |
 |
Title 21 - Food and Drugs |
|
Chapter I - Food and Drug Administration, Department of Health and Human Services |
|
SubChapter E - Animal Drugs, Feeds, and Related Products |
|
Part 524 - Ophthalmic and Topical Dosage Form New Animal Drugs |
|
Fluocinolone Topical and Otic Dosage Forms |
§ 524.1484g - Neomycin, thiabendazole, and dexamethasone solution.
-
§ 524.1484g Neomycin, thiabendazole, and dexamethasone solution.
(a) Specifications. Each milliliter of solution contains 40 milligrams (mg) thiabendazole, 3.2 mg neomycin (from neomycin sulfate), and 1 mg dexamethasone.
(b) Sponsors. See Nos. 000010 and 026637 017033 in § 510.600(c) of this chapter.
(c) Conditions of use in dogs and cats -
(1) Amount. In treating dermatoses affecting areas other than the ear, the surface of the lesions should be well moistened (2 to 4 drops per square inch) twice daily. In treating otitis externa, instill 5 to 15 drops in the ear twice daily. Treat for up to 7 days.
(2) Indications for use. As an aid in the treatment of bacterial, mycotic, and inflammatory dermatoses and otitis externa.
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[40 FR 13873, Mar. 27, 1975, as amended at 62 FR 63271, Nov. 28, 1997; 79 FR 10971, Feb. 27, 2014; 80 FR 61297, Oct. 13, 2015; 84 FR 39184, Aug. 9, 2019; 88 FR 16549, Mar. 20, 2023]